Ken Griffin Cardiol Therapeutics Inc. Put Options Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
Put Options
3 transactions
Others Institutions Holding CRDL
# of Institutions
45Shares Held
5.5MCall Options Held
162KPut Options Held
7.4K-
Tejara Capital LTD London, X01.72MShares$3.32 Million1.26% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD1.47MShares$2.83 Million0.55% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9924KShares$1.78 Million0.36% of portfolio
-
Lion Street Advisors, LLC273KShares$527,4320.19% of portfolio
-
Foundations Investment Advisors, LLC162KShares$312,5630.01% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $120M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...